Becker's Healthcare November 14, 2024
Under the first Trump administration, telehealth benefitted, The Wall Street Journal reported Nov. 14.
For example, in 2020, federal regulators waived a rule requiring in-person evaluations before prescribing controlled substances via telemedicine, a change that advocates say has expanded access to critical opioid-use disorder treatments, especially for rural patients.
However, some telemedicine companies have faced scrutiny for overprescribing stimulants under this policy.
The current waiver is set to expire on Dec. 31, but in October,...